Close Brothers Aim Vct PLC
12 July 2007
Close Brothers AIM VCT PLC Interim Management Statement
Introduction
I am pleased to present your Company's first interim management statement for
the period from 1st March to the 11th July 2007 as required by the UK Listing
Authority's Disclosure and Transparency Rule 4.3.
Performance
The net asset values (NAV) as at 4 July 2007, as announced on the London Stock
Exchange RNS service on 6 July 2007 for the Ordinary and D shares were 85.9p and
131.4p respectively (after accounting for the dividends). Including the 2.5p
dividends declared but not yet paid on both classes of shares the Ordinary and D
shares appreciated by 0.7% and 6.8% respectively in the period to 4 July 2007.
This compares with a total return for the AIM index of 11.8%. There have been no
material events since the latest net asset value was struck on 4 July 2007, save
a commitment to one new investment in the D share portfolio of £0.3 m.
Portfolios
In the period to 4 July 2007 we have made 8 new investments in the D portfolio
at a total cost of £2.2m and one new investment in the Ordinary portfolio at a
cost of £0.4 m. Both portfolios took some profits in Tanfield, and in the D
portfolio we accepted a cash bid for the holding in Computer Software Group, and
Mears shares for the holding in Careforce. As at 4th July 2007 the Ordinary
portfolio was 81.6% and the D portfolio was 58.8% invested in qualifying
investments.
New Investments in the Period
Company Ordinary Portfolio D Share Portfolio
Cost £000 Cost £000
Neuropharm PLC 400.0 400.0
Claimar PLC - 200.0
B Global PLC - 150.0
Idox PLC - 362.0
Tasty PLC - 149.0
Pressure Technology PLC - 300.0
Invu PLC - 200.0
Mount Engineering PLC - 431.0
Top Ten Qualifying Holdings (as at 4th July 2007)
Ordinary Portfolio Carrying Value
£000s
Tanfield Group PLC 1,796.7
Bond International Software PLC 1,245.9
Pipex Communications PLC 1,089.8
Colliers Cre PLC 981.9
Pilat Media Global PLC 973.6
The Clapham House Group PLC 939.7
Mears PLC 926.5
Claimar Care Group PLC 833.9
Cello Group PLC 765.0
Zetar PLC 731.4
D Portfolio Carrying Value
£000s
Tanfield Group PLC 1,507.5
Claimar Care Group PLC 1,123.4
Mattioli Woods PLC 692.7
Vertu Motors PLC 600.0
Neuropharm PLC 560.6
Work Group PLC 480.2
Hexagon Human Capital PLC 477.2
Zetar PLC 457.2
Idox PLC 434.7
Mount Engineering PLC 430.8
All of the top ten qualifying holdings are quoted and valued at bid price as at
4th July.
Dividends
As stated in the Preliminary Announcement of the results for the year to 28
February 2007, the Board has declared a dividend of 2.5p to all Ordinary
shareholders and 2.5p to all D shareholders. All Ordinary and D shareholders on
the register on 6 July will be paid on the 3 August 2007.
Share buybacks and discount
During the period to 11 July 2007, the company repurchased 376,951 Ordinary
shares. Additionally the Company purchased 146,191 D shares in the period.
As at 4th July, the discount of the Ordinary share price to NAV per share was
6.9%. The discount for the D shares was 8.3%.
12 July 2007
For further information please contact Andrew Buchanan/Kate Tidbury of Close
Investments Limited
Tel: 0207 426 4139
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.